← All companies

IONS

Ionis Pharmaceuticals, Inc.

IONS Nasdaq Pharmaceutical Preparations EDGAR ↗

$54.49

+1.21 +2.27%

Key statistics

from XBRL data in SEC filings

Market cap

$9.06B

Revenue (TTM)

$874M

Net income (TTM)

-$565M

EPS (TTM)

$-3.46

P/E ratio

—

Dividend yield

—

Free cash flow

-$320M

Cash

$350M

Total assets

$2.99B

Gross margin

—

52-week range

$40.03 – $86.74

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Regulation FD disclosure Jul 10, 2026 8-K Regulation FD disclosure; Other events Jul 9, 2026 8-K Regulation FD disclosure; Other events Jun 24, 2026 8-K Other events Jun 12, 2026 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure Jun 8, 2026 8-K Regulation FD disclosure; Other events May 28, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release) Apr 29, 2026 8-K Regulation FD disclosure; Other events Apr 21, 2026 8-K Director or officer change; Regulation FD disclosure Mar 9, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 25, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Regulation FD disclosure; Other events Jan 7, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Nov 17, 2025 8-K Regulation FD disclosure; Other events Nov 10, 2025 8-K/A Entered a material agreement Nov 3, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Regulation FD disclosure; Other events Sep 22, 2025 8-K Regulation FD disclosure; Other events Sep 2, 2025 8-K Regulation FD disclosure; Other events Aug 21, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K Director or officer change Jun 12, 2025 8-K Shareholder vote results Jun 10, 2025 8-K Other events May 19, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release) Apr 30, 2025 8-K Entered a material agreement Mar 12, 2025 10-K Fiscal year ended 2024-12-31 Feb 19, 2025 8-K Results of operations (earnings release) Feb 19, 2025 8-K Other events Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Other events Sep 12, 2024 8-K Other events Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024